Whittier Trust’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $61.3M | Sell |
240,790
-1,518
| -0.6% | -$327K | 0.6% | 40 |
|
|
2026
Q1 | $50.1M | Buy |
242,308
+5,083
| +2% | +$1.13M | 0.57% | 43 |
|
|
2025
Q4 | $53.1M | Buy |
237,225
+1,578
| +0.7% | +$359K | 0.58% | 41 |
|
|
2025
Q3 | $55.1M | Sell |
235,647
-1,383
| -0.6% | -$282K | 0.63% | 38 |
|
|
2025
Q2 | $44M | Buy |
237,030
+9,073
| +4% | +$1.69M | 0.53% | 44 |
|
|
2025
Q1 | $47.8M | Sell |
227,957
-16,778
| -7% | -$3.26M | 0.67% | 36 |
|
|
2024
Q4 | $43.5M | Sell |
244,735
-2,311
| -0.9% | -$425K | 0.57% | 40 |
|
|
2024
Q3 | $48.8M | Buy |
247,046
+2,720
| +1% | +$508K | 0.65% | 37 |
|
|
2024
Q2 | $41.9M | Buy |
244,326
+2,504
| +1% | +$415K | 0.59% | 38 |
|
|
2024
Q1 | $44M | Buy |
241,822
+70,206
| +41% | +$12.1M | 0.64% | 33 |
|
|
2023
Q4 | $26.6M | Buy |
171,616
+1,528
| +0.9% | +$223K | 0.43% | 55 |
|
|
2023
Q3 | $25.4M | Buy |
170,088
+798
| +0.5% | +$117K | 0.45% | 52 |
|
|
2023
Q2 | $22.8M | Sell |
169,290
-3,148
| -2% | -$462K | 0.4% | 60 |
|
|
2023
Q1 | $27.5M | Sell |
172,438
-138
| -0.1% | -$21.1K | 0.5% | 45 |
|
|
2022
Q4 | $27.9M | Sell |
172,576
-1,059
| -0.6% | -$162K | 0.54% | 43 |
|
|
2022
Q3 | $23.3M | Sell |
173,635
-8,375
| -5% | -$1.2M | 0.49% | 51 |
|
|
2022
Q2 | $27.9M | Sell |
182,010
-663
| -0.4% | -$101K | 0.56% | 40 |
|
|
2022
Q1 | $29.6M | Sell |
182,673
-959
| -0.5% | -$139K | 0.5% | 49 |
|
|
2021
Q4 | $24.9M | Buy |
183,632
+3,211
| +2% | +$379K | 0.4% | 61 |
|
|
2021
Q3 | $19.5M | Buy |
180,421
+603
| +0.3% | +$68.9K | 0.35% | 75 |
|
|
2021
Q2 | $20.3M | Buy |
179,818
+4,010
| +2% | +$452K | 0.36% | 68 |
|
|
2021
Q1 | $19M | Sell |
175,808
-1,003
| -0.6% | -$107K | 0.37% | 65 |
|
|
2020
Q4 | $18.9M | Sell |
176,811
-14,569
| -8% | -$1.4M | 0.4% | 62 |
|
|
2020
Q3 | $16.8M | Buy |
191,380
+4,857
| +3% | +$457K | 0.4% | 60 |
|
|
2020
Q2 | $18.3M | Buy |
186,523
+25,228
| +16% | +$2.22M | 0.51% | 48 |
|
|
2020
Q1 | $12.3M | Sell |
161,295
-334
| -0.2% | -$28.4K | 0.4% | 67 |
|
|
2019
Q4 | $14.3M | Sell |
161,629
-234
| -0.1% | -$19.4K | 0.38% | 72 |
|
|
2019
Q3 | $12.3M | Buy |
161,863
+1,177
| +0.7% | +$80.7K | 0.35% | 78 |
|
|
2019
Q2 | $11.7M | Sell |
160,686
-206
| -0.1% | -$16.2K | 0.34% | 81 |
|
|
2019
Q1 | $13M | Sell |
160,892
-49,319
| -23% | -$4.03M | 0.4% | 66 |
|
|
2018
Q4 | $19.4M | Sell |
210,211
-2,021
| -1% | -$178K | 0.67% | 34 |
|
|
2018
Q3 | $20.1M | Sell |
212,232
-4,360
| -2% | -$413K | 0.63% | 33 |
|
|
2018
Q2 | $20.1M | Sell |
216,592
-4,364
| -2% | -$426K | 0.66% | 33 |
|
|
2018
Q1 | $20.9M | Sell |
220,956
-3,089
| -1% | -$339K | 0.7% | 29 |
|
|
2017
Q4 | $21.7M | Sell |
224,045
-14,700
| -6% | -$1.39M | 0.76% | 28 |
|
|
2017
Q3 | $21.2M | Buy |
238,745
+1,062
| +0.4% | +$80.8K | 0.77% | 30 |
|
|
2017
Q2 | $17.2M | Sell |
237,683
-409
| -0.2% | -$27.5K | 0.67% | 36 |
|
|
2017
Q1 | $15.5M | Sell |
238,092
-1,311
| -0.5% | -$82.4K | 0.63% | 38 |
|
|
2016
Q4 | $15M | Sell |
239,403
-5,958
| -2% | -$364K | 0.64% | 38 |
|
|
2016
Q3 | $15.5M | Sell |
245,361
-1,698
| -0.7% | -$110K | 0.67% | 34 |
|
|
2016
Q2 | $15.3M | Sell |
247,059
-3,940
| -2% | -$240K | 0.67% | 37 |
|
|
2016
Q1 | $14.3M | Sell |
250,999
-3,494
| -1% | -$195K | 0.63% | 39 |
|
|
2015
Q4 | $15.1M | Buy |
254,493
+7,160
| +3% | +$412K | 0.68% | 32 |
|
|
2015
Q3 | $13.5M | Sell |
247,333
-8,467
| -3% | -$551K | 0.65% | 37 |
|
|
2015
Q2 | $17.2M | Sell |
255,800
-6,080
| -2% | -$397K | 0.76% | 29 |
|
|
2015
Q1 | $15.3M | Sell |
261,880
-5,484
| -2% | -$331K | 0.7% | 35 |
|
|
2014
Q4 | $17.5M | Sell |
267,364
-11,101
| -4% | -$700K | 0.83% | 23 |
|
|
2014
Q3 | $16.1M | Sell |
278,465
-2,827
| -1% | -$157K | 0.78% | 34 |
|
|
2014
Q2 | $15.9M | Sell |
281,292
-66,516
| -19% | -$3.49M | 0.78% | 32 |
|
|
2014
Q1 | $17.9M | Sell |
347,808
-100,639
| -22% | -$5.09M | 0.92% | 20 |
|
|
2013
Q4 | $23.7M | Sell |
448,447
-15,163
| -3% | -$745K | 1.21% | 14 |
|
|
2013
Q3 | $20.7M | Buy |
463,610
+1,173
| +0.3% | +$52K | 1.12% | 16 |
|
|
2013
Q2 | $19.1M | Buy |
+462,437
| New | +$20.2M | 1.07% | 19 |
|
Other funds holding ABBV
ECSS
ATO
Whittier Trust's ABBV Position: Q2 2026 in Review
Whittier Trust reduced its AbbVie (ABBV) stake by 0.63% in Q2 2026, selling an estimated $327K and leaving 240,790 shares worth $61.3M. The position accounts for 0.6% of the portfolio, ranked #40.
Whittier Trust first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 1,993 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Whittier Trust held 240,790 shares of AbbVie worth $61.3M as of Q2 2026.
- Whittier Trust sold 1,518 AbbVie shares in Q2 2026, an estimated $327K.
- AbbVie made up 0.6% of Whittier Trust's portfolio in Q2 2026, its #40 holding.
- Whittier Trust first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 1,993 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Whittier Trust's 13F filing for Q2 2026, filed 28 Jul 2026.